Not applicableActive Not RecruitingNCT05295992
What this trial is testing
Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach
Who this might be right for
Muscle-Invasive Bladder Carcinoma
Varian, a Siemens Healthineers Company 110